Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Zentalis Pharmaceuticals (ZNTL)

  • Technical Exchange News
  • May 31, 2024, 19:25 UTC
  • 28
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Qualigen Therapeutics Inc. (QLGN)

  • Technical Exchange News
  • May 31, 2024, 19:25 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

Helius Medical Technologies Inc (HSDT)

  • Technical Exchange News
  • May 31, 2024, 19:24 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cue Health Inc (HLTH)

  • Technical Exchange News
  • May 31, 2024, 19:24 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

GeoVax Labs Inc. (GOVX)

  • Technical Exchange News
  • May 31, 2024, 19:24 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

GeoVax Labs Inc. (GOVXW)

  • Technical Exchange News
  • May 31, 2024, 19:24 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Inhibrx (INBX)

  • Technical Exchange News
  • May 31, 2024, 07:12 UTC
  • 107
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Inhibrx, Inc. - Common Stock. New value: Inhibrx Biosciences, Inc. - Common Stock.

Comment Full text

Vincerx Pharma Inc. (VINC)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Protagenic Therapeutics Inc. (PTIXW)

  • Technical Exchange News
  • May 31, 2024, 02:09 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 579
  • 580
  • 581
  • 582
  • 583
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191987)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125298)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin